Senior insider sale
Chief Scientific Officer at ADAPTIVE BIOTECHNOLOGIES CORP — senior position signals high conviction
$1.99M
116.16K shares
What this filing means
ROBINS HARLAN S plans to sell 116.16K shares of ADAPTIVE BIOTECHNOLOGIES CORP valued at approximately $1.99M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/16/2026ACC: 0001958244-26-000386
Officer· Chief Scientific Officer
Since Jun 2019
116.16K
Shares to sell
$1.99M
Approx. market value
6.16K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Acquired as compensation -- Performance Awards
Compensation
3/7/2026
6.16KTotal acquired6.16K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/7/2026 | Acquired as compensation -- Performance Awards Compensation | 6.16K | — |
| Total | 6.16K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
100K
Market value
$1.74M
6/15/2026
—Completed
Units to sell
10K
Market value
$148.3K
4/8/2026
Planned — Approximate Date
NASDPlanned
Units to sell
6.16K
Market value
$106.1K
6/16/2026
Total
Units
116.16K
Value
$1.99M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/15/2026 | 100K | $1.74M | — | Completed |
4/8/2026 | 10K | $148.3K | — | Completed |
| Planned — Approximate Date | ||||
6/16/2026 | 6.16K | $106.1K | NASD | Planned |
| Total | 116.16K | $1.99M | ||